ScholarIQanswers from OpenAlex

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database

PaperCitations, authors & open-access status

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database have?

ScholarIQcitation count

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database published?

ScholarIQyear

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database has 2020 year in the ScholarIQ index.

What is the open-access status of Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database?

ScholarIQoa status

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database has gold oa status in the ScholarIQ index.

What is the DOI of Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database?

ScholarIQdoi

The DOI for Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database is on the source record.

What is the OpenAlex record for Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database?

ScholarIQopenalex

The OpenAlex for Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating COPD Patients Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy Within a Large US Health Insurer Database is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial